IPCI


Stock Update (NASDAQ:IPCI): IntelliPharmaCeutics Intl Inc (USA) Announces Third Quarter 2015 Results

IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid …

Stock Update (NASDAQ:IPCI): IntelliPharmaCeutics Intl Inc (USA) Updates Status of Tentative Approvals of Generic Focalin XR(R)

IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid …

Stock Update (NASDAQ:IPCI): IntelliPharmaCeutics Intl Inc (USA) Announces Second Quarter 2015 Results

IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid …

Thursday Morning Pre-Market Insights: Direxion Daily CSI 300 China A Share Bull 2X Shares, IntelliPharmaCeutics Intl Inc (USA), iDreamSky Technology Ltd (ADR), QLogic Corporation

Direxion Daily CSI 300 China A Share Bull 2X Shares (NYSEARCA:CHAU) soared nearly 27% in pre-market trading on Thursday to $26.99 as China’s …

Stock Update (NASDAQ:IPCI): IntelliPharmaCeutics Intl Inc (USA) Updates Status of Tentative Approvals of Generic Focalin XR(R)

IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid …

Stock Update (NASDAQ:IPCI): IntelliPharmaCeutics Intl Inc (USA) Updates Status of Tentative Approvals of Generic Focalin XR(R)

IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral …

Maxim Weighs in on Biotech Stocks: Sophiris Bio Inc (SPHS), Pluristem Therapeutics Inc. (PSTI), IntelliPharmaCeutics Intl Inc (IPCI)

Maxim Group’s healthcare analyst Jason Kolbert weighed in today with research reports on the Canadian urology company Sophiris Bio Inc (NASDAQ:SPHS), Israeli stem cell company Pluristem Therapeutics Inc. (NASDAQ:PSTI), …

Company Update (NASDAQ:IPCI): FDA Grants Fast Track Designation for IntelliPharmaCeutics Intl Inc (USA) Rexista(TM) Oxycodone XR Incorporating PODRAS(TM) Technology

IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid …

Stock Update (NASDAQ:IPCI): IntelliPharmaCeutics Intl Inc (USA) Announces Agreement to Acquire Real Property and Status of 5mg Strength of its Generic Focalin XR(R)

IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid …

Analysts Weigh in on IntelliPharmaCeutics International Inc. (IPCI) as Rexista NDA Pathway Shortened

Analysts are weighing in on IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI), following the news that the FDA has provided the company with guidance regarding its abuse-deterrent Rexista …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts